BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. ✅
International journal of clinical and experimental pathology (Int J Clin Exp Pathol ) Vol: 8 Issue 5 Pages: 5217-23 Pub: 2015 Epub: 2015 May 1 Authors Peng L , Kang S , Yin Z , Jia R , Song X , Li L , Li Z , Zou Y , Liang X , Li L , He C , Ye G , Yin L , Shi F , Lv C , Jing B , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅
Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
|
Effects of Dietary Inclusion of Dry Hydrastis canadensis on Laying Performance, Egg Quality, Serum Biochemical Parameters and Cecal Microbiota in Laying Hens. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 11 Issue 5 Pages: Pub: 2021 May 13 Epub: 2021 May 13 Authors Tzeng TJ , Liu TY , Lin CW , Chang PE , Liao PX , Yang WY , Cheng CY , Liao PC , Chiang WD , Ding ST , Lin YY , |
|
|
Microbiome and metabolome analyses reveal significant alterations of gut microbiota and bile acid metabolism in ETEC-challenged weaned piglets by dietary berberine supplementation. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1428287 Pub: 2024 Epub: 2024 Jun 25 Authors Nie X , Lu Q , Yin Y , He Z , Bai Y , Zhu C , |
|
|
Microbiome and metabolome analyses reveal significant alterations of gut microbiota and bile acid metabolism in ETEC-challenged weaned piglets by dietary berberine supplementation. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1428287 Pub: 2024 Epub: 2024 Jun 25 Authors Nie X , Lu Q , Yin Y , He Z , Bai Y , Zhu C , |
|
|
Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 131 Issue Pages: 110669 Pub: 2020 Nov Epub: 2020 Sep 13 Authors Yao Y , Chen H , Yan L , Wang W , Wang D , |
|
|
Berberine combined with stachyose improves glycometabolism and gut microbiota through regulating colonic microRNA and gene expression in diabetic rats. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 284 Issue Pages: 119928 Pub: 2021 Nov 1 Epub: 2021 Sep 1 Authors Li C , Cao H , Huan Y , Ji W , Liu S , Sun S , Liu Q , Lei L , Liu M , Gao X , Fu Y , Li P , Shen Z , |
|
|
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 588079 Pub: 2020 Epub: 2020 Sep 24 Authors Chen H , Zhang F , Zhang J , Zhang X , Guo Y , Yao Q , |
|
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. ✅
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
|
|
In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. ✅
Phytotherapy research : PTR (Phytother Res ) Vol: 17 Issue 3 Pages: 217-21 Pub: 2003 Mar Epub: Authors Mahady GB , Pendland SL , Stoia A , Chadwick LR , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
